Blog
KROS Pipeline Catalysts: DMD Phase II and ALS Plans for 2026
Keros Therapeutics KROS enters 2026 with a clearer catalyst stack and a tighter operational focus. The near-term setup is led by rinvatercept, with study starts and regulatory interactions now
Ultra Short-Term Income ETF (BENJ) Hits Fresh 52-Week High
For investors seeking momentum, Horizon Landmark ETF BENJ is probably on the radar now. The fund just hit a 52-week high and is up 4.4% from its 52-week low price of $50.07 per share.
But are there
ETFs to Gain as NVIDIA Views $1 Trillion in Chip Orders by 2027
In a stunning revelation at its latest annual GTC conference, NVIDIA NVDA CEO Jensen Huang announced that the company now expects to secure up to $1 trillion in chip orders for its next-generation
Genuine Parts Stock Down 15% YTD: Buy, Sell or Hold the Stock Now?
Genuine Parts Company GPC, based in Atlanta, is a distributor of automotive and industrial replacement parts and materials. The company operates a vast network of more than 10,800 locations
W&T Offshore Q4 Loss Wider Than Expected, Revenues Increase Y/Y
W&T Offshore, Inc. WTI reported a fourth-quarter 2025 adjusted loss of 14 cents per share, wider than the Zacks Consensus Estimate of a loss of 9 cents. The bottom line improved from the year-ago
Healthpeak & Janus Living Announce Launch of Janus Living IPO
Healthpeak Properties, Inc. DOC announced that its pure-play RIDEA-structured senior housing REIT, Janus Living, has launched its initial public offering (IPO) of 37,000,000 shares of its Class A-1
Here's Why You Should Hold Cencora Stock in Your Portfolio for Now
Cencora COR is well-poised for growth on the back of a robust U.S. Healthcare Solutions business and product launches. However, intense competition is a concern.
This Zacks Rank #3 (Hold) company’s
3 IT Services Stocks to Buy Right Now From a Prospering Industry
Should You Continue to Hold Bio-Techne Stock in Your Portfolio?
Bio-Techne TECH continues to expand its portfolio and enter adjacent markets via acquisitions and strategic investments. Strength in international markets underscores the company’s growth potential
BAYRY Reports Positive Data on Kidney Drug in Non-Diabetic CKD
Bayer BAYRY announced that finerenone achieved the primary endpoint in the late-stage FIND-CKD study, marking a key milestone in expanding its use to patients with non-diabetic chronic kidney
Can QUBT's Diverse Quantum Technologies Support Long-Term Growth?
Quantum Computing Inc. QUBT or QCi is positioning itself as a diversified quantum and photonics technology company, building a portfolio of solutions that span optimization computing, photonic AI
Is Alphabet Stock's 25.55X PE Still Worth it? Buy, Sell, or Hold?
Alphabet GOOGL shares are overvalued, as suggested by a Value Score of D. The GOOGL stock is trading at a forward 12-month price/earnings (P/E) of 25.55X compared with the broader Zacks Computer &
Is Penumbra (PEN) a Solid Growth Stock? 3 Reasons to Think "Yes"
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to
AVGO Boosts AI Growth With New Optical, Ethernet Tech: What's Ahead?
Broadcom AVGO is expanding its portfolio of open, scalable and energy-efficient AI infrastructure solutions with the introduction of advanced technologies at the ongoing 2026 Optical Fiber
SL Green to Sell 7 Dey Street to GO Residential for $222.6M
SL Green Realty Corp. SLG announced that it has entered into a contract to sell the residential and retail portions of 7 Dey Street to GO Residential for $222.6 million, while retaining the
Expanding Wafer Fab Equipment Spending Aids KLAC: What's Ahead?
KLA KLAC is benefiting from strong spending in the Wafer Fabrication Equipment (“WFE”) market. The company expects the WFE market to grow from about $110 billion in 2025 to the mid-$130 billion
The Trade Desk's CTV Push: Can Ventura, OpenAds, and Kokai Deliver?
The Trade Desk TTD is pushing beyond demand-side execution and into the plumbing of connected TV (“CTV”). The goal is clear: make streaming inventory more measurable, more transparent, and easier to
TTD Trades at a Discounted P/E: Should You Buy the Stock?
The Trade Desk TTD has pulled back sharply, and that reset is forcing investors to separate near-term noise from longer-cycle positioning. The stock now screens as inexpensive on a forward earnings
Is Estee Lauder's Fragrance Business Rising on Luxury Demand?
The Estee Lauder Companies’ EL fragrance business highlights how demand for luxury offerings continues to underpin performance in the category. The company’s second-quarter fiscal 2026 results
The Trade Desk Growth Story Hinges on CTV Strength and AI Push
The Trade Desk TTD sits at the center of one of digital advertising’s most important shifts —budgets moving toward connected TV (“CTV”) that can be planned and measured with the same discipline as
Walmart's Valuation Looks Rich: Should You Stay Invested in the Stock?
Walmart Inc. WMT continues to command a premium valuation in the retail sector, reflecting investor confidence in its resilient business model and strong execution. The stock is currently trading at
BXP Sees Solid Demand, Signs Long-Term Leases at 360 Park Avenue South
Boston Properties BXP recently provided an update regarding long-term leases signed at 360 Park Avenue South, a 450,000-square-foot premier workplace in Midtown South. The leases included both new
4 Textile-Apparel Stocks Set to Benefit From Strong Industry Momentum
Key Reasons to Add Kimco Realty Stock to Your Portfolio Now
Kimco Realty Corp.’s KIM focus on grocery-anchored centers and mixed-use assets and balance sheet-strengthening moves will help the retail REIT bank on growth scopes.
Last month, Kimco reported
ResMed (RMD) Upgraded to Buy: Here's What You Should Know
ResMed (RMD) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the


